Ranbaxy Pharmaceuticals Inc. has launched an authorized generic version of Caduet, indicated for the treatment of high blood pressure and high cholesterol. Ranbaxy said Tuesday that the product is being introduced in the U.S. market under an agreement with Pfizer Inc.
Christopher Arington has been promoted to vice chairman and chief executive officer of authorized generic drug maker Prasco Laboratories. Previously president and chief operating officer, he takes the CEO reins from his father, Prasco chairman and founder E. Thomas Arington.
Helen of Troy Ltd. plans to buy the PUR water filtration product business from Procter & Gamble Co.
Horizon Pharma Inc. has launched Duexis, a proprietary single-tablet combination of ibuprofen (800 mg) and famotidine (26.6 mg), in the United States.
Nipro Diagnostics Inc. has won the 2011 Manufacturer of the Year Award from the Manufacturers Association of Florida (MAF). The diabetes management product company said Monday that it was recognized in the large company category (more than 500 employees).
Kraft Foods Inc. has appointed the chairmen and chief executive officers of the two companies it will form next year when it wraps up a planned spin-off of its grocery business.
Consumer product sales and marketing specialist Crossmark plans to buy national marketing agency New Concepts in Marketing Inc. (NCiM). Terms of the deal weren’t disclosed.
Ranbaxy Laboratories Ltd. and Teva Pharmaceuticals USA Inc. have entered an agreement on their respectives launches of generic versions of Lipitor, Pfizer’s cholesterol-reducing medication. Jerusalem-based Teva Pharmaceutical Industries Ltd.
In what it called the largest generic product launch in U.S. history, Watson Pharmaceuticals Inc. has begun shipping an authorized generic version of Pfizer’s blockbuster cholesterol-lowering drug Lipitor. The shipment of Watson’s Lipitor generic signals the start of the "generic wave.
Watson Pharmaceuticals Inc. has gained approval from the Food and Drug Administration for Vestura (3 mg drospirenone and 0.02 mg ethinyl estradiol), a birth control pill.
TheraBiogen Inc. has kicked off a radio ad campaign for its TheraMax homeopathic nasal spray brand as part of a comprehensive marketing program.
Qualitest Pharmaceuticals has received approval from the Food and Drug Administration for Myzilra tablets, an oral contraceptive. The company said Monday that the FDA approved Myzilra tablets (levonorgestrel and ethinyl estradiol) 0.05 mg/0.03 mg, 0.075 mg/0.04 mg, 0.125 mg/0.
Procter & Gamble Co.’s P&G Beauty & Grooming unit has launched of StyleUnited, which it called "the first truly personalized site" that brings beauty and fashion together to provide "a total style resource." P&G said Tuesday that styleunited.
Perrigo Co. has received final approval from the Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for guaifenesin extended-release tablets (600 mg), indicated for chest congestion.
Not Your Mother’s hair care products are slated to hit shelves at more than 7,500 new retail outlets early next year. Parent company Demert Brands Inc.
Thomas Haughey has been named president and Paul Campanelli has been appointed chief operating officer at Par Pharmaceutical Cos.
